Clinical Comparison of Bone Scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP
- 1 May 1984
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica. Diagnosis
- Vol. 25 (3) , 217-223
- https://doi.org/10.1177/028418518402500310
Abstract
The bone-imaging agents MDP, DPD and HDP were compared radiochemically (only minor differences were found) in 12 patients with prostatic and 12 patients with breast carcinoma. Each patient received both MDP and either DPD or HDP. The scintigraphic examinations were compared visually and quantitatively. The uptake ratio normal bone/soft tissue was higher for DPD and HDP than for MDP. The ratio pathologic bone/normal bone was highest for MDP, particularly for prostatic carcinoma. The differences in this ratio for breast carcinoma were in general non-significant. The observed differences were minor and of little practical importance.This publication has 5 references indexed in Scilit:
- A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastasesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1983
- TC-99M HYDROXYMETHYLENE DIPHOSPHONATE AND TC-99M METHYLENE DIPHOSPHONATE - BIOLOGICAL AND CLINICAL COMPARISON - CONCISE COMMUNICATION1983
- A Crossover Study Comparing Tc-99m-labeled HMDP and MDP in PatientsClinical Nuclear Medicine, 1981
- Quality control of 99mTc-radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1980
- A New Complex of99mTc for Skeletal ImaqinqRadiology, 1971